Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Luca Barella is active.

Publication


Featured researches published by Luca Barella.


Annals of the New York Academy of Sciences | 2004

α-Tocopherol Affects Androgen Metabolism in Male Rat

Luca Barella; Cristina Rota; Elisabeth Stöcklin; Gerald Rimbach

Abstract: The Alpha‐Tocopherol Beta‐Carotene Cancer Prevention Study has provided the first evidence implicating vitamin E in hormone synthesis. The effect of vitamin E on stereoidogenesis in testes and adrenal glands was assessed in growing rats using Affymetrix gene‐chip technology. Dietary supplementation of rats with vitamin E (60 mg/kg feed) for a period of 429 days caused a significant repression of genes encoding for proteins centrally involved in the uptake (low‐density lipoprotein receptor) and de novo synthesis (for example, 7‐dehydrocholesterol reductase, 3‐hydroxy‐3‐methylglutaryl coenzyme A synthase, 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase, isopentenyl‐diphosphate delta‐isomerase, and farnesyl pyrophosphate synthetase) of cholesterol, the precursor of all steroid hormones. The present investigation indicates that dietary vitamin E may induce changes in stereoidogenesis by affecting cholesterol homeostasis.


Annals of Nutrition and Metabolism | 2006

Cortical Gene Expression in the Vitamin E-Deficient Rat: Possible Mechanisms for the Electrophysiological Abnormalities of Visual and Neural Function

Stephen Hyland; David P.R. Muller; Samantha M. Hayton; Elisabeth Stoecklin; Luca Barella

In mammals, severe and chronic deficiency of vitamin E (α-tocopherol) is associated with a characteristic neurological syndrome. Previously, we have shown that this syndrome is accompanied by electrophysiological abnormalities of neural and visual function. To investigate the molecular basis of the observed abnormalities, we used microarrays to monitor the expression of ∼14,000 genes in the cerebral cortex from rats which had received diets containing 0, 1.25 and 5.0 mg/kg diet of all-rac-α-tocopheryl acetate for 14 months. Compared to the groups receiving 1.25 and 5.0 mg/kg α-tocopheryl acetate, a total of 11 genes were statistically significantly upregulated (≧1.3-fold) and 34 downregulated (≤1.3-fold) in the vitamin E-deficient group. Increased expression was observed for the genes encoding the antioxidant enzyme catalase and the axon guidance molecule tenascin-R, while decreased expression was detected for genes encoding protein components of myelin and determinants of neuronal signal propagation. Thus our observations suggest that vitamin E deficiency results in transcriptional alterations in the cerebral cortex of the rat which are consistent with the observed neurological and electrophysiological alterations.


Annals of Nutrition and Metabolism | 2008

The Natural Compound Ascorbigen Modulates NADPH-Quinone Oxidoreductase (NQO1) mRNA and Enzyme Activity Levels in Cultured Liver Cells and in Laboratory Rats

Anika E. Wagner; Hubert Hug; Richard Gössl; Georges Riss; Bernd Mussler; Volker Elste; Gerald Rimbach; Luca Barella

Ascorbigen (ABG) is a natural compound that represents a breakdown product of the glucosinolates that are present in Brassica vegetables. It is postulated that ABG may have anticarcinogenic activity; however, the underlying molecular and cellular mechanisms are largely unknown. In the present study we investigated the effect of ABG on the mRNA and enzyme activity levels of NADPH-quinone oxidoreductase (NQO1), which is centrally involved in the detoxification of xenobiotics, in cultured liver cells and in rats. The mRNA levels of NQO1 showed an increase of up to 100% in cultured liver cells (HepG2) following incubation with different concentrations of ABG (3–100 µmol/l) compared to control cells. Furthermore, NQO1 activity was elevated (up to 20%) by ABG treatment. The in vitro results were confirmed in rats who received either 5 mg/day ABG or vehicle for 7 days. Significantly higher mRNA (a 90% increase) and enzyme activity levels (a 40% increase) of NQO1 were detected in the liver of ABG-treated rats as compared to control animals. Current data indicate that ABG is a moderate inducer of the phase II enzyme NQO1, both in cultured hepatocytes and in vivo.


Archive | 2003

Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies

Luca Barella; Regina Goralczyk; Klaus Jung; Michael Lein; Ulrich Siler; Elisabeth Stoecklin; Karin Wertz


Journal of Nutrition | 2005

Lycopene Effects on Rat Normal Prostate and Prostate Tumor Tissue

Ulrich Siler; Angelika Herzog; Volker Spitzer; Nicole Seifert; Athanasios Denelavas; Petra Buchwald Hunziker; Luca Barella; Willi Hunziker; Michael Lein; Regina Goralczyk; Karin Wertz


Archive | 2003

Novel use of lycopene

Luca Barella; Regina Goralczyk; Ulrich Siler; Karin Wertz


Journal of Plant Physiology | 2005

Comparative quantification of pharmacodynamic parameters of chiral compounds (RRR- vs. all-rac-α tocopherol) by global gene expression profiling

Patrick Y. Muller; Thomas Netscher; Jan Frank; Elisabeth Stoecklin; Gerald Rimbach; Luca Barella


Archive | 2006

Method for Measuring and Comparing the Activity of Biologically Active Compounds

Luca Barella; Patrick Y. Muller; Thomas Netscher; Elisabeth Stöcklin


Archive | 2004

Vitamin e for facilitating the synchronization of circadian rhythm

Luca Barella; Gerald Rimbach; Michael Piesche


Archive | 2004

Use of vitamin e

Luca Barella; Gerald Rimbach

Researchain Logo
Decentralizing Knowledge